Poorly Differentiated Clusters: Clinical Impact in Colorectal Cancer

Clinical Colorectal Cancer

Volumn 16, Issue 1, 2017, Pages 9-15

  Barresi, Valeria ^a   Reggiani Bonetti, Luca ^b   Ieni, Antonio ^a   Caruso, Rosario Alberto ^a   Tuccari, Giovanni ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Epithelial mesenchymal transition; Grading; KRAS; Microsatellite instability; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; CANCER GRADING; CANCER PATIENT; CANCER PROGNOSIS; COLORECTAL CANCER; HISTOPATHOLOGY; HUMAN; MEDICAL DECISION MAKING; MOLECULARLY TARGETED THERAPY; POORLY DIFFERENTIATED CLUSTER; REVIEW; TREATMENT RESPONSE; CANCER STAGING; COLORECTAL TUMOR; PATHOLOGY; PROGNOSIS;

COLORECTAL NEOPLASMS; HUMANS; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS;

EID: 84997241503     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2016.06.002     Document Type: Review

References (53)

1. 1 Ferlay, J., Soerjomataram, I., Dikshit, R., et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136 (2015), E359–E386.
2. 2 Hamilton, S.R., Bosman, F.T., Boffetta, P., et al. Carcinoma of the colon and rectum. Bosman, T., Carneiro, F., Hruban, R.H., Theise, N.D., (eds.) WHO Classification of Tumors of the Digestive System, 2010, IARC Press, Lyon, France, 134–146.
3. 3 O'Connell, J.B., Maggard, M.A., Ko, C.Y., Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 96 (2004), 1420–1425.
4. 4 Hari, D.M., Leung, A.M., Lee, J.H., et al. AJCC Cancer Staging Manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment?. J Am Coll Surg 217 (2013), 181–190.
5. 5 Ueno, H., Kajiwara, Y., Shimazaki, H., et al. New criteria for histologic grading of colorectal cancer. Am J Surg Pathol 36 (2012), 193–201.
6. 6 Barresi, V., Reggiani Bonetti, L., Branca, G., Di Gregorio, C., Ponz de Leon, M., Tuccari, G., Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading. Virchows Arch 461 (2012), 621–628.
7. 7 Barresi, V., Reggiani Bonetti, L., Ieni, A., Branca, G., Baron, L., Tuccari, G., Histological grading based on the count of poorly differentiated clusters in pre-operative biopsy predicts nodal involvement and pTNM stage in colorectal cancer patients. Hum Pathol 45 (2014), 268–275.
8. 8 Ueno, H., Hase, K., Hashiguchi, Y., et al. Site-specific tumor grading system in colorectal cancer: multicenter pathologic review of the value of quantifying poorly differentiated clusters. Am J Surg Pathol 38 (2014), 197–204.
9. 9 Barresi, V., Reggiani Bonetti, L., Ieni, A., Domati, F., Tuccari, G., Prognostic significance of grading based on the counting of poorly differentiated clusters in colorectal mucinous adenocarcinoma. Hum Pathol 46 (2015), 1722–1729.
10. 10 Barresi, V., Branca, G., Vitarelli, E., Tuccari, G., Micropapillary pattern and poorly differentiated clusters represent the same biological phenomenon in colorectal cancer: a proposal for a change in terminology. Am J Clin Pathol 142 (2014), 375–383.
11. 11 Kim, J.W., Shin, M.K., Kim, B.C., Clinicopathologic impacts of poorly differentiated cluster-based grading system in colorectal carcinoma. J Korean Med Sci 30 (2015), 16–23.
12. 12 Barresi, V., Reggiani Bonetti, L., Domati, V.F., Baron, L., Prognostic relevance of histopathological features in signet ring cell carcinoma of the colorectum. Virchows Arch, 2016, 10.1007/s00428-016-1983-0 [Epub ahead of print].
13. 13 Barresi, V., Tuccari, G., Colorectal carcinoma grading quantified by counting poorly differentiated clusters: is it feasible on endoscopic biopsies?. Am J Surg Pathol 37 (2013), 943–945.
14. 14 Kikuchi, R., Takano, M., Takagi, K., et al. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum 38 (1995), 1286–1295.
15. 15 Beaton, C., Twine, C.P., Williams, G.L., Radcliffe, A.G., Systematic review and meta-analysis of histopathological factors influencing the risk of lymph node metastasis in early colorectal cancer. Colorectal Dis 15 (2013), 788–797.
16. 16 Barresi, V., Branca, G., Ieni, A., et al. Poorly differentiated clusters (PDCs) as a novel histological predictor of nodal metastases in pT1 colorectal cancer. Virchows Arch 464 (2014), 655–662.
17. 17 Nakadoi, K., Tanaka, S., Kanao, H., et al. Management of T1 colorectal carcinoma with special reference to criteria for curative endoscopic resection. J Gastroenterol Hepatol 27 (2012), 1057–1062.
18. 18 Repici, A., Hassan, C., De Paula Pessoa, D., et al. Efficacy and safety of endoscopic submucosal dissection for colorectal neoplasia: a systematic review. Endoscopy 44 (2012), 137–150.
19. 19 Nascimbeni, R., Burgart, L.J., Nivatvongs, S., Larson, D.R., Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 45 (2002), 200–206.
20. 20 Egashira, Y., Yoshida, T., Hirata, I., et al. Analysis of pathological risk factors for lymph node metastasis of submucosal invasive colon cancer. Mod Pathol 17 (2004), 503–511.
21. 21 Tateishi, Y., Nakanishi, Y., Taniguchi, H., Shimoda, T., Umemura, S., Pathological prognostic factors predicting lymph node metastasis in submucosal invasive (T1) colorectal carcinoma. Mod Pathol 23 (2010), 1068–1072.
22. 22 Kye, B.H., Jung, J.H., Kim, H.J., Kang, S.G., Cho, H.M., Kim, J.G., Tumor budding as a risk factor of lymph node metastasis in submucosal invasive T1 colorectal carcinoma: a retrospective study. BMC Surg, 12, 2012, 16.
23. 23 Watanabe, T., Itabashi, M., Shimada, Y., et al., Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol 17 (2012), 1–29.
24. 24 Quirke, P., Risio, M., Lambert, R., von Karsa, L., Vieth, M., Quality assurance in pathology in colorectal cancer screening and diagnosis—European recommendations. Virchows Arch 458 (2011), 1–19.
25. 25 Ueno, H., Hase, K., Hashiguchi, Y., et al. Novel risk factors for lymph node metastasis in early invasive colorectal cancer: a multi-institution pathology review. J Gastroenterol 49 (2014), 1314–1323.
26. 26 Leslie Sobin, M.G., Wittekind, C., TNM Classification of Malignant Tumors. 2009, Wiley Blackwell, Chichester, UK.
27. 27 Edge, S.B., Byrd, D.R., Compton, C.C., Fritz, A.G., Greene, F.L., Trotti, A.E., AJCC Cancer Staging Manual. 7th ed., 2010, Springer, New York, NY.
28. 28 Benson, A.B. 3rd, Schrag, D., Somerfield, M.R., et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for Stage II colon cancer. J Clin Oncol 22 (2004), 3408–3419.
29. 29 Di Gregorio, C., Fante, R., Roncucci, L., et al. Clinical features, frequency and prognosis of Dukes' A colorectal carcinoma: a population-based investigation. Eur J Cancer 32A (1996), 1957–1962.
30. 30 Reggiani Bonetti, L., Di Gregorio, C., De Gaetani, C., et al. Lymph node micrometastasis and survival of patients with Stage I (Dukes' A) colorectal carcinoma. Scand J Gastroenterol 46 (2011), 881–886.
31. 31 Santos, C., López-Doriga, A., Navarro, M., et al. Clinicopathological risk factors of Stage II colon cancer: results of a prospective study. Colorectal Dis 15 (2013), 414–422.
32. 32 Barresi, V., Reggiani Bonetti, L., Ieni, A., Branca, G., Tuccari, G., Histologic prognostic markers in stage IIA colorectal cancer: a comparative study. Scand J Gastroenterol 51 (2016), 314–320.
33. 33 Ueno, H., Shinto, E., Kajiwara, Y., et al. Prognostic impact of histological categorisation of epithelial-mesenchymal transition in colorectal cancer. Br J Cancer 111 (2014), 2082–2090.
34. 34 Hay, E.D., An overview of epithelio-mesenchymal transformation. Acta Anat (Basel) 154 (1995), 8–20.
35. 35 Kajiwara, Y., Ueno, H., Hashiguchi, Y., et al. Heterogeneity of metalloproteinase expression in colorectal cancer—relation of molecular findings to basic morphology. Anticancer Res 1 (2011), 567–575.
36. 36 Kajiwara, Y., Ueno, H., Hashiguchi, Y., et al. Expression of l1 cell adhesion molecule and morphologic features at the invasive front of colorectal cancer. Am J Clin Pathol 136 (2011), 138–144.
37. 37 Huh, J.W., Lee, J.H., Kim, H.R., Kim, Y.J., Prognostic significance of lymphovascular or perineural invasion in patients with locally advanced colorectal cancer. Am J Surg 206 (2013), 758–763.
38. 38 Zhou, Y., Wang, H., Gong, H., Cao, M., Zhang, G., Wang, Y., Clinical significance of perineural invasion in stages II and III colorectal cancer. Pathol Res Pract 211 (2015), 839–844.
39. 39 Chou, J.F., Row, D., Gonen, M., Liu, Y.H., Schrag, D., Weiser, M.R., Clinical and pathologic factors that predict lymph node yield from surgical specimens in colorectal cancer: a population-based study. Cancer 116 (2010), 2560–2570.
40. 40 Kobayashi, H., Mochizuki, H., Kato, T., et al., Study Group for Rectal Cancer Surgery of the Japanese Society for Cancer of the Colon and Rectum. Lymph node ratio is a powerful prognostic index in patients with stage III distal rectal cancer: a Japanese multicenter study. Int J Colorectal Dis 26 (2011), 891–896.
41. 41 Kinoshita, O., Kishimoto, M., Murayama, Y., et al. The number of metastatic lymph nodes exhibiting poorly differentiated clusters predicts survival in patients with pStage III colorectal cancer. Int J Colorectal Dis 31 (2016), 283–290.
42. 42 Chen, Y.-G., Liu, X., Wang, X.-S., Classifying the stage IV colorectal cancer: prognostic impact of radical resection for colorectal liver metastases and proposal for a new staging system. Cell Biochem Biophys 67 (2013), 1445–1449.
43. 43 Kobayashi, H., Kotake, K., Sugihara, K., Prognostic scoring system for stage IV colorectal cancer: is the AJCC sub-classification of stage IV colorectal cancer appropriate?. Int J Clin Oncol 18 (2013), 696–703.
44. 44 Lee, W.-S., Kang, M., Bae, J.-H., Lee, J.-I., Ha, S.Y., Clinical impact of tumor infiltrating lymphocytes for survival in curatively resected stage IV colon cancer with isolated liver or lung metastasis. Ann Surg Oncol 20 (2013), 697–702.
45. 45 Ueno, H., Konishi, T., Ishikawa, Y., et al. Prognostic value of poorly differentiated clusters in the primary tumor in patients undergoing hepatectomy for colorectal liver metastasis. Surgery 157 (2015), 899–908.
46. 46 Van den Eynden, G.G., Bird, N.C., Majeed, A.W., Van Laere, S., Dirix, L.Y., Vermeulen, P.B., The histological growth pattern of colorectal cancer liver metastases has prognostic value. Clin Exp Metastasis 29 (2012), 541–549.
47. 47 Cunningham, D., Humblet, Y., Siena, S., et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351 (2004), 337–345.
48. 48 De Roock, W., Claes, B., Bernasconi, D., et al. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis. Lancet Oncol 11 (2010), 753–762.
49. 49 Barresi, V., Bonetti, L.R., Bettelli, S., KRAS, NRAS, BRAF mutations and high counts of poorly differentiated clusters of neoplastic cells in colorectal cancer: observational analysis of 175 cases. Pathology 47 (2015), 551–556.
50. 50 Haigis, K.M., Kendall, K.R., Wang, Y., et al. Differential effects of oncogenic KRas and N-Ras on proliferation, differentiation and tumor progression in the colon. Nat Genet 40 (2008), 600–608.
51. 51 Shao, D.D., Xue, W., Krall, E.B., et al. KRAS and YAP1 converge to regulate EMT and tumor survival. Cell 3 (2014), 171–184.
52. 52 Rosty, C., Williamson, E.J., Clendenning, M., et al. Should the grading of colorectal adenocarcinoma include microsatellite instability status?. Hum Pathol 45 (2014), 2077–2084.
53. 53 Barresi, V., Bonetti, L.R., Correlation between microsatellite instability status and grading assessed by the counting of poorly differentiated clusters in colorectal cancer. Hum Pathol, 46, 2015, 1063.